(USD) | Jun 2023 | Q/Q |
---|---|---|
Revenue | 74.5B | +8% |
Gross Profit | 3B | -1% |
Cost Of Revenue | 71.5B | +9% |
Operating Income | 1.1B | +12% |
Operating Expenses | 1.9B | -8% |
Net Income | 958MM | +22% |
G&A | 1.9B | -5% |
Amortization | 62MM | -6% |
Interest Expense | 47MM | -41% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Veradigm's (MDRX) latest partnership is likely to promote value-based care initiatives for healthcare providers and the patients they serve.
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. MOD, SFM, MOH and MCK are sound enough to meet financial obligations.
Ecolab's (ECL) strength in its business raises optimism about the stock.
Applied Materials, PulteGroup, Arcos Dorados Holdings, McKesson, and NetEase are part of the Zacks Screen of the Week article.
IRVING, Texas, September 27, 2023--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2024 financial results after market close on Wednesday, November 1, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Catalent's (CTLT) product and service launches and a slew of strategic deals raise optimism about the stock.
DexCom's (DXCM) CGM systems will make dietary assessment through AI-enabled RxFood app, which automatically interprets food images for calorie count in Canada.
Applied Materials (AMAT), PulteGroup (PHM), Arcos Dorados (ARCO), McKesson (MCK) and NetEase (NTES) could be compelling picks for investors in the current scenario.
Tesla stock and social media giant Meta Platforms forge new buy points and are on today's IBD Screen Of The Day.
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.